Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
3.590
+0.160 (4.66%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Alterity Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| Market Capitalization | 61 | 60 | 14 | 11 | 22 | 44 | |
| Market Cap Growth | 66.79% | 327.48% | 23.14% | -47.27% | -50.72% | 259.32% | |
| Enterprise Value | 27 | 57 | 6 | -5 | -4 | 17 | |
| Last Close Price | 3.43 | 4.09 | 1.81 | 2.79 | 6.11 | 13.00 | |
| PS Ratio | 13.79 | 16.78 | 5.22 | 4.36 | 6.11 | 13.45 | |
| PB Ratio | 1.69 | 2.15 | 1.52 | 0.75 | 0.88 | 1.92 | |
| P/TBV Ratio | 1.69 | 2.15 | 1.52 | 0.75 | 0.88 | 1.92 | |
| EV/Sales Ratio | 6.01 | 15.97 | 2.22 | - | - | 5.37 | |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.00 | |
| Net Debt / Equity Ratio | -0.90 | -0.95 | -0.90 | -0.68 | -0.98 | -0.92 | |
| Net Debt / EBITDA Ratio | 2.80 | 2.77 | 0.64 | 1.07 | 2.24 | 1.85 | |
| Net Debt / FCF Ratio | 3.58 | 3.54 | 0.99 | 0.78 | 2.79 | 1.62 | |
| Asset Turnover | 0.20 | 0.17 | 0.17 | 0.11 | 0.14 | 0.20 | |
| Quick Ratio | 21.68 | 12.62 | 3.10 | 5.58 | 6.79 | 10.56 | |
| Current Ratio | 21.98 | 12.98 | 3.54 | 6.17 | 7.07 | 10.92 | |
| Return on Equity (ROE) | -47.02% | -43.23% | -104.47% | -47.38% | -38.97% | -81.39% | |
| Return on Assets (ROA) | -32.54% | -28.09% | -52.66% | -26.64% | -25.85% | -43.62% | |
| Return on Capital Employed (ROCE) | -32.30% | -34.50% | -141.60% | -63.80% | -43.60% | -49.70% | |
| Earnings Yield | -15.94% | -13.31% | -91.15% | -80.84% | -41.06% | -26.24% | |
| FCF Yield | -15.76% | -12.55% | -60.11% | -117.35% | -39.72% | -29.72% | |
| Buyback Yield / Dilution | -74.72% | -75.31% | -50.29% | -0.91% | -41.79% | -89.62% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.